论文部分内容阅读
目的 :在临床实践中对垂体腺瘤进行分期 ,并以指导临床治疗。方法 :依据肿瘤的大小及患者内分泌情况进行分期 ,以T表示肿瘤的大小 ,S表示内分泌紊乱的程度 ,临床分期 :Ⅰ期T1S1;Ⅱ期T2 S1;Ⅲ期T3S1;Ⅳ期T4 S1、T1～ 4 S2 。结果 :分析了自 1975～ 1990年收治的 6 31例垂体瘤患者 ,控制率为 :Ⅰ期 94.7% ,Ⅱ期 92 .9% ,Ⅲ期84.6 % ,Ⅳ期 6 3 .3%。经统计学处理 :Ⅰ期、Ⅱ期与Ⅲ期间 ,Ⅰ期、Ⅱ期与Ⅳ期 ,Ⅲ期与Ⅳ期间疗效有差异(P <0 .0 5 )。结论 :TS分期可预示垂体瘤患者的预后 ,不同的期别要采用不同的治疗方案
Objective: To staging pituitary adenoma in clinical practice and guiding clinical treatment. Methods: According to the size of the tumor and the patient’s endocrine situation, the tumor size was expressed by T, and S was the degree of endocrine disorder. The clinical stage was stage Ⅰ T1S1; stage Ⅱ T2 S1; stage Ⅲ T3S1; stage Ⅳ T4 S1, 4 S2. Results: The data of 631 pituitary adenomas treated from 1975 to 1990 were analyzed. The control rates were 94.7% in stage Ⅰ, 92.9% in stage Ⅱ, 84.6% in stage Ⅲ, and 63.3% in stage Ⅳ. The results showed that there were significant differences between the two groups (stage Ⅰ, stage Ⅱ and stage Ⅲ, stage Ⅰ, stage Ⅱ and stage Ⅳ, stage Ⅲ and stage Ⅳ) (P <0.05). Conclusion: TS staging can predict the prognosis of patients with pituitary tumors, different periods to use different treatment options